| Product Name | MF | CAS | Details |
|---|
| CHMFL-BMX-078 | C33H35N7O6 | 1808288-51-8 | Details |
| (±)-Zanubrutinib | C27H29N5O3 | 1633350-06-7 | Details |
| Bosutinib | C26H29Cl2N5O3 | 380843-75-4 | Details |
| Nilotinib | C28H22F3N7O | 641571-10-0 | Details |
| Btk inhibitor 2 | C24H25N5O3 | 1558036-85-3 | Details |
| CSF1R-IN-1 | C25H20F3N5O2 | 2095849-04-8 | Details |
| BMS-935177 | C31H26N4O3 | 1231889-53-4 | Details |
| Dasatinib hydrochloride | C22H27Cl2N7O2S | 854001-07-3 | Details |
| TG 100572 Hydrochloride | C26H27Cl2N5O2 | 867331-64-4 | Details |
| AG 1295 | C16H14N2 | 71897-07-9 | Details |
| Dovitinib lactate | C24H27FN6O4 | 692737-80-7 | Details |
| Masitinib mesylate | C29H34N6O4S2 | 1048007-93-7 | Details |
| Motesanib | C22H23N5O | 453562-69-1 | Details |
| Sunitinib Malate | C26H33FN4O7 | 341031-54-7 | Details |
| Sunitinib | C22H27FN4O2 | 557795-19-4 | Details |
| Vandetanib | C22H24BrFN4O2 | 443913-73-3 | Details |
| Multi-kinase inhibitor 1 | C20H17F3N4O3 | 778274-97-8 | Details |
| PD173074 | C28H41N7O3 | 219580-11-7 | Details |
| Toceranib phosphate | C22H28FN4O6P | 874819-74-6 | Details |
| Tirbanibulin dihydrochloride | C20H21ClN4O | 1038395-65-1 | Details |
| Tirbanibulin Mesylate | C27H33N3O6S | 1080645-95-9 | Details |
| Ensartinib hydrochloride | C26H28Cl3FN6O3 | 2137030-98-7 | Details |
| Tyrosine kinase inhibitor | C31H31FN6O5 | 1021950-26-4 | Details |
| PF-573228 | C22H20F3N5O3S | 869288-64-2 | Details |
| SU14813 maleate | C23H27FN4O4.C4H4O4 | 849643-15-8 | Details |
| Ningetinib Tosylate | C38H37FN4O8S | 1394820-77-9 | Details |
| 3-Hydroxy Midostaurin | C35H30N4O5 | 179237-49-1 | Details |
| INDY | C12H13NO2S | 1169755-45-6 | Details |
| KB SRC 4 | C32H23ClN8 | 1380088-03-8 | Details |
| SU16f | C24H22N2O3 | 251356-45-3 | Details |
| PF-06465469 | C30H33N7O2 | 1407966-77-1 | Details |
| Vorolanib | C23H26FN5O3 | 1013920-15-4 | Details |
| Acrizanib | C20H18F3N7O2 | 1229453-99-9 | Details |
| Vecabrutinib | C22H24ClF4N7O2 | 1510829-06-7 | Details |
| Lck inhibitor 2 | C18H17N5O2 | 944795-06-6 | Details |
| Osteogenic Growth Peptide (10-14) | C24H29N5O7 | 105250-85-9 | Details |
| N-Deshydroxyethyl Dasatinib | C20H22ClN7OS | 910297-51-7 | Details |
| BRD4 degrader AT1 | C48H58ClN9O5S3 | 2098836-45-2 | Details |
| dTRIM24 | C55H68N8O13S2 | 2170695-14-2 | Details |
| BI-3663 | C44H42F3N7O12 | 2341740-84-7 | Details |
| BSJ-03-123 | C47H56N10O11 | 2361493-16-3 | Details |
| PROTAC ERα Degrader-2 | C42H61N5O8 | 1351169-29-3 | Details |
| PROTAC RIPK degrader-2 | C52H65N7O11S3 | 1801547-16-9 | Details |
| PROTAC RIPK degrader-6 | C43H48N6O11S2 | 2089205-64-9 | Details |
| SNIPER(BRD)-1 | C53H66ClN9O8S2 | 2095244-54-3 | Details |
| PAC | C94H107N13O16 | 2158322-33-7 | Details |
| MS4078 | C45H52ClN9O8S | 2229036-62-6 | Details |
| MZP-54 | C55H66ClN7O9S | 2010159-47-2 | Details |
| MZP-55 | C57H70ClN7O10S | 2010159-48-3 | Details |
| dBET6 | C42H45ClN8O7S | 1950634-92-0 | Details |
| PROTAC BET Degrader-10 | C39H39ClN8O6S | 1957234-97-7 | Details |
| PROTAC BET degrader-2 | C41H42N10O6 | 2093388-33-9 | Details |
| A1874 | C58H62Cl3F2N9O7S | 2064292-12-0 | Details |
| VZ185 | C53H67FN8O8S | 2306193-61-1 | Details |
| PROTAC FLT-3 degrader 1 | C52H61N9O9S2 | 2230826-81-8 | Details |
| BETd-246 | C48H55N11O10 | 2140289-17-2 | Details |
| PROTAC FAK degrader 1 | C47H56F3N9O8S2 | 2301916-69-6 | Details |
| MT-802 | C41H41N9O8 | 2231744-29-7 | Details |
| ZXH-3-26 | C38H37ClN8O7S | 2243076-67-5 | Details |
| THAL-SNS-032 | C40H52N8O10S2 | 2139287-33-3 | Details |
| BI-4464 | C28H28F3N5O4 | 1227948-02-8 | Details |
| NV03 | C19H27N5O2S | 2448341-58-8 | Details |
| PROTAC Bcl2 degrader-1 | C45H45BrN6O10S | 2378801-85-3 | Details |
| PROTAC Mcl1 degrader-1 | C45H45BrN6O8S | 2163793-38-0 | Details |
| PROTAC BRD4 ligand-1 | C23H18F2N4O5S | 2313230-51-0 | Details |
| ARCC-4 | C53H56F3N7O7S2 | 1973403-00-7 | Details |
| Cereblon modulator 1 | C22H18ClF2N3O4 | 1860875-51-9 | Details |
| Rogaratinib | C23H26N6O3S | 1443530-05-9 | Details |
| WEHI-345 analog | C23H25N7O | 1354825-62-9 | Details |
| Tyrosine kinase-IN-1 | C26H28FN5O | 705946-27-6 | Details |
| PCI-33380 | 1022899-36-0 | Details |
| CNX-500 | C48H68N10O9S | 1202758-21-1 | Details |
| N-piperidine Ibrutinib hydrochloride | C22H23ClN6O | 2231747-18-3 | Details |
| Androgen receptor antagonist 1 | C21H25ClN4O3 | 1338812-36-4 | Details |
| Desmorpholinyl Navitoclax-NH-Me | C44H51ClF3N5O5S3 | 2365172-82-1 | Details |
| SJF620 | C41H44N8O7 | 2376187-16-3 | Details |
| XZ739 | C65H76ClF3N8O12S3 | 2365172-19-4 | Details |
| PROTAC BRD4 Degrader-5 | C50H62ClN9O8S2 | 2409538-70-9 | Details |
| BSJ-03-204 | C43H48N10O8 | 2349356-09-6 | Details |
| Thalidomide | C13H10N2O4 | 50-35-1 | Details |
| ARV-825 | C46H47ClN8O9S | 1818885-28-7 | Details |
| Navitoclax-piperazine | C47H56ClF3N6O5S3 | 2143096-93-7 | Details |
| Ibrutinib-biotin | C56H80N12O9S | 1599432-18-4 | Details |
| tBID | C11H3Br4N3O2 | 1639895-85-4 | Details |
| Rp-cAMPS triethylammonium salt | C16H27N6O5PS | 151837-09-1 | Details |
| Rp-cAMPS sodium salt | C10H13N5NaO5PS | 142439-94-9 | Details |
| TAK-659 hydrochloride | C17H22ClFN6O | 1952251-28-3 | Details |
| Conteltinib | C32H45N9O3S | 1384860-29-0 | Details |
| Lanraplenib succinate | C27H31N9O5 | 1800047-00-0 | Details |
| Tivozanib | C22H19ClN4O5 | 475108-18-0 | Details |
| ENMD-2076 | C21H25N7 | 934353-76-1 | Details |
| A-770041 | C34H39N9O3 | 869748-10-7 | Details |
| Ibrutinib D5 | C25H24N6O2 | 1553977-17-5 | Details |
| BPR1K871 | C25H28ClN7O2S | 2443767-35-7 | Details |
| SIAIS178 | C50H62ClN11O6S2 | 2376047-73-1 | Details |
| SU4312 | C17H16N2O | 5812-07-7 | Details |
| BSJ-04-132 | C42H49N11O7 | 2349356-39-2 | Details |
| CDK9-IN-10 | C22H16O5 | 3542-63-0 | Details |
| KB02-JQ1 | C38H43Cl2N7O6S | 2384184-44-3 | Details |
| CP-10 | C44H49N13O7 | 2366268-80-4 | Details |
| Product Total： Product Page： | ||||
| 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 | ||||